Advertisement
FDA Alert
FDA Alert
09/11/2023

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.
09/11/2023
Conference Coverage
Conference Coverage
09/08/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers reported on the treatment approaches and outcomes of patients with T‑cell prolymphocytic leukemia after allogeneic transplant in a multicenter, retrospective study.
09/08/2023
Conference Coverage
Conference Coverage
09/07/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine how momelotinib impacts patients’ overall transfusion burden.
09/07/2023
Conference Coverage
Conference Coverage
09/06/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether cancer-related cognitive impairment impacts older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy.
09/06/2023
research summary
research summary
08/24/2023

Leigh Precopio

Leigh Precopio
Metastatic uveal melanoma has been a difficult condition to treat due to a lack of effective treatment options. Authors of a recent review aimed to determine the benefit of immune checkpoint inhibition...
08/24/2023
Research Summary
Research Summary
06/14/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine the impact of midostaurin in adult patients with FLT3-mutated acute myeloid leukemia.
06/14/2023
Conference Coverage
Conference Coverage
05/30/2023

Anthony Calabro, MA

Anthony Calabro, MA
In their presentation at the 48th ONS Congress, in San Antonio, Texas, Denise Nicholson BSN, RN and Colleen Nevins DNP, RN, CNE describe the best practices for advance care planning conversations and review...
05/30/2023
Conference Coverage
Conference Coverage
05/22/2023

Anthony Calabro, MA

Anthony Calabro, MA
In her presentation at the 48th ONS Congress, in San Antonio, Texas, Gayle Somerstein, RN, OCN, BSN, MPH, MBA, reviews common adult learning styles that can be tailored to each patient’s individualized...
05/22/2023
Research Summary
Research Summary
05/17/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a multicenter, randomized, open-label, phase 3 trial, researchers set out to determine whether an advanced surgical therapy, isolated hepatic perfusion, could improve outcomes among previously untreated...
05/17/2023
Conference Coverage
Conference Coverage
05/16/2023

Jessica Bard

Jessica Bard
Hypercholesterolemia and diabetes have a minimal impact on major adverse cardiovascular events (MACE) risk in patients with prostate cancer (PCa) who are treated with androgen deprivation therapy (ADT),...
05/16/2023